Drug Trial Radar · NCT06544694
A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease
Last checked: Nov 20, 2026Latest source record: Mar 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
80
Actual
Start
Oct 8, 2024
Primary completion
Mar 21, 2025
Study completion Mar 21, 2025
Sponsor
- Lead sponsor
- Alcon ResearchIndustry
- Sponsor type
- Industry
- First posted
- Aug 9, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the effect of AR-15512 ophthalmic solution 0.003% (0.003% AR-15512) on ocular surface characteristics of subjects with dry eye disease (DED).
Conditions
- Dry Eye Disease
Interventions
0.003% AR-15512 ophthalmic solutionDrug
Investigational ophthalmic solution administered via topical instillation
Artificial TearsOther
Commercially available, preservative-free lubricant eye drops administered via topical instillation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Least Squares Mean Percentage Change From Baseline in Goblet Cell Density at Day 90 for 0.003% AR-15512Time frame: Day 1 pre-instillation (Baseline), Day 90 post instillation
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Butchertown Clinical Trials
Louisville, Kentucky
Oculus Research
Garner, North Carolina
Wilmington Eye
Leland, North Carolina
CORE, Inc.
Shelby, North Carolina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.